Skip to main content

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Study Results Published, Shows Potential for Digital Therapeutics in Pain Management

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting about new research related to machine learning and digital health solutions. The research, which was published in “Pain Reports,”evaluated the personalized efficacy of digital therapeutics for pain management, linking the reduction of back pain for users in a digital posture training. Conducted in partnership with the Integrative Pain Laboratory, School of Public Health at the University of Haifa, the study analyzed data from 3,610 users who reported substantial reduction in back pain after three weeks of using the company’s posture-training program. The company noted that users’ profiles moderated time fluctuations of pain levels and posture quality over time. In addition, Dario analyzed the data to assess how the use of machine learning could account for unique individual needs. The results of the study provided context and a framework to assist in understanding the effectiveness of digital therapeutics in helping individuals manage pain. “Back pain is a common condition that affects a majority of adults at some point in their life, and early research on the impact of posture biofeedback training technology as a means to improve pain is promising,” said Dario vice president of clinical and scientific affairs Yifat Hershcovitz, PhD, in the press release. “Our latest research helps explain the role of personalization in digital therapeutics and how we can use biofeedback data and machine learning to optimize user care, drive efficacy and meaningful results for users.”

To view the full press release, visit

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.